期刊文献+

利培酮对未经治疗首发精神分裂症患者血糖和血脂的影响 被引量:1

Effects of risperidone on blood glucose and lipid in first-episode,drug-naive patients with schizophrenia
原文传递
导出
摘要 目的观察口服利培酮对未经治疗的首发精神分裂症患者血糖和血脂的影响。方法:对62例未经治疗的首发精神分裂症患者,给予利培酮2~6mg,1次/d,连续口服12周。于治疗前和治疗4、8、12周末,用阳性症状和阴性症状量表(PANSS)评定精神症状,用不良反应症状量表(TESS)评定不良反应,用葡萄糖氧化酶法测定血糖(Glu)、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)浓度。结果:服药12周后,62例患者中22例(35.48%)患者治愈,38例(61.29%)显著好转,2例(3.23%)有效。22例(35.48%)有不良反应记录(失眠、口干、便秘、震颤和静坐不能等)。服药后第4,8,12周末的TC和TG浓度,第8周末的HDL浓度,第12周末的LDL浓度与治疗前相比差异均有统计学意义(P<0.01,P<0.05,P<0.05),Glu浓度各时段组间比较,差异均无统计学意义(P>0.05)。结论:利培酮口服可有效缓解首发精神分裂症患者的症状,不良反应较轻;利培酮对血糖无明显影响,但可使TC和TG浓度明显升高。 Objective: To observe the effects of risperidone on blood glucose and lipid in first-episode, drug-naive patients with schizophrenia. Methods: Sixty-two first-episode, drug-naive patients with schizophrenia were given risperidone 2 -6 mg once daily for 12 weeks. The mental symptoms were assessed with PANSS, adverse reactions were assessed with TESS, and blood glucose, total cholesterol (TC), triglycerides (TG), high-density lipoproteins (HDL), and low-density lipoproteins (LDL) were measured with glucose oxidase methods before administration and in the end of the fourth, eighth, and twelfth week after administration. Results: Of the sixty-two patients, 22 (35.48%) were cured, 38(61.29% ) marked improved, and 2 (3.23%) responded after 12 weeks of treatment. Twenty-two patients developed adverse reactions including insomnia, dry mouth, constipation, tremor, and akathisia, The differences were statistically significant as compared TC and TG concentration in the end of the fourth, eighth, and twelfth week during treatment, HDL concentration in the end of eighth week during treatment, and LDL concentration in the end of the twelfth week during treatment with those before treatment ( P 〈 0. 01, P 〈 0. 05, P 〈 0. 05 ). The difference as in blood glucose concentration were no statistically significant as compared before medication with after medication ( P 〉 0. 05 ). Conclusion: Risperidone may effective relieve the symptoms of first-episode patients with schizophrenia and its adverse reactions are relatively mild. Risperidone has no effects on blood glucose, but it may obviously elevate the levels of TC and TG.
机构地区 北京回龙观医院
出处 《药物不良反应杂志》 2007年第5期324-328,共5页 Adverse Drug Reactions Journal
关键词 利培酮 精神分裂症 血糖 血脂 risperidone schizophrenia blood glucose, blood lipid
  • 相关文献

参考文献11

  • 1Fontaine KR, Heo M, Harrigan EP, et al. Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate[J]. Psychiatry Res, 2001, 101 (3) :277-288.
  • 2Wirshing DA. Schizophrenia and obesity:impact of antipsychotic medications [J]. J Clin Psychiatry, 2004, 65 (Suppl 18) :13-26.
  • 3Jin H, Meyer JM, Jeste DV. Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases [J]. Ann Clin Psychiatry, 2002, 14(1) :59-64.
  • 4Newcomer JW. Second-generation catypical antipsychotics and metabolic effects: a comprehensive literature review[J]. CNS Drugs, 2005, 19(Suppl 1) :1-93.
  • 5Boston PF, Dursun SM, Reveley MA. Tholesterol and mental disorder [ J ]. Br Psychiatry, 1996, 169 (6) :682-689.
  • 6Boston PF, Dursun SM, Zafar R, et al. Serum TC lesterol and treatment resistance in schizophrenia[ J ]. Biol Psychiatry, 1996, 40(6): 542-543.
  • 7Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, dug-naive patients with schizophrenia[ J]. Am J Psychiatry, 2003, 160 (2) : 284 -289.
  • 8Saari K, Lindeman S, Koponen H, et al. Higher serum triglyceride levels in early-onset schizophrenia [ J ]. Am J Psychiatry, 2004, 161 ( 1 ) : 176.
  • 9Cavazzoni P, Mukhopadhyay N, Carlson C, et al. Retrospective analysis of risk factors in patients with treatment-emergent diabetes during clinical trials of antipsychotic medications [ J ]. Br J Psychiatry Suppl, 2004, 47 :S94-101.
  • 10Nasrallah HA, Newcomer JW. Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care [ J ]. J Clin Psychopharmacol, 2004, 24(5 Suppl 1 ) :S7-14.

同被引文献17

引证文献1

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部